• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[A case report of successful treatment for rectosigmoid cancer with peritoneal dissemination after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].

作者信息

Ishida Manako, Miyazawa Tomonori, Ebe Kazuyu, Koide Norihiko, Fujita Nobuhiro, Honma Kenji, Ikarashi Toshihiko

机构信息

Joetsu General Hospital, Japan.

出版信息

Gan To Kagaku Ryoho. 2013 Jan;40(1):103-5.

PMID:23306929
Abstract

A 60-year-old woman underwent emergency operation for ileus due to rectosigmoid cancer. Intraoperative cytology and peritoneal dissemination were positive. After performing sigmoid colostomy, she underwent neoadjuvant radiation therapy (40 Gy)and eight courses of a XELOX and bevacizumab regimen. FDG-PET did not indicate FDG accumulation after chemoradiotherapy, thus, we performed low anterior resection. Peritoneal dissemination and washing cytology were negative in the second operation. Neoadjuvant chemoradiotherapy with XELOX and bevacizumab were useful for down staging in patients with advanced colorectal cancer.

摘要

相似文献

1
[A case report of successful treatment for rectosigmoid cancer with peritoneal dissemination after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].
Gan To Kagaku Ryoho. 2013 Jan;40(1):103-5.
2
[A case report of pathologically complete response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].[新辅助化疗联合奥沙利铂、氟尿嘧啶和贝伐单抗治疗局部晚期直肠癌获病理完全缓解1例报告]
Gan To Kagaku Ryoho. 2012 Jun;39(6):1001-3.
3
[A case wherein bevacizumab/XELOX combination therapy was remarkably effective for the treatment of extensive dissemination in advanced colon cancer, and the primary lesion could be resected].[贝伐单抗/XELOX联合疗法对晚期结肠癌广泛播散治疗效果显著且可切除原发灶的病例]
Gan To Kagaku Ryoho. 2013 Nov;40(11):1545-8.
4
[Neoadjuvant chemoradiotherapy with capecitabine and oxaliplatin for the treatment of locally advanced lower rectal cancer].
Gan To Kagaku Ryoho. 2013 Nov;40(12):2020-2.
5
[Recurrent liver sigmoid cancer responding remarkably to neoadjuvant chemotherapy using bevacizumab/XELOX: report of a case].[复发性肝乙状结肠癌对使用贝伐单抗/ XELOX的新辅助化疗反应显著:病例报告]
Gan To Kagaku Ryoho. 2011 Sep;38(9):1541-3.
6
[A case of advanced rectal cancer that showed complete response to the addition of XELOX+bevacizumab therapy to preoperative chemoradiotherapy with S-1/CPT-11].[1例晚期直肠癌患者,术前使用S-1/CPT-11进行同步放化疗,加用XELOX+贝伐单抗治疗后显示完全缓解]
Gan To Kagaku Ryoho. 2014 May;41(5):653-5.
7
[A case of necrotizing fasciitis developed in a patient with recurrent rectal cancer treated with chemotherapy].
Gan To Kagaku Ryoho. 2013 May;40(5):663-5.
8
A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.奥沙利铂和卡培他滨新辅助放化疗治疗直肠癌的 II 期研究。
Cancer Lett. 2011 Nov 28;310(2):134-9. doi: 10.1016/j.canlet.2011.06.026. Epub 2011 Jul 5.
9
[A case in which chemotherapy-resistant sigmoid colon cancer was controlled effectively by radiotherapy and resection].[一例通过放疗和切除有效控制化疗耐药性乙状结肠癌的病例]
Gan To Kagaku Ryoho. 2013 Nov;40(12):1996-8.
10
Phase II trial of neoadjuvant chemotherapy with XELOX plus bevacizumab for locally advanced rectal cancer.XELOX 联合贝伐珠单抗新辅助化疗治疗局部进展期直肠癌的 II 期临床试验。
Jpn J Clin Oncol. 2011 Aug;41(8):1041-4. doi: 10.1093/jjco/hyr084.